Clinical Trial: Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231419) titled 'Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy' on Nov. 13.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine in participants with pain associated with diabetic peripheral neuropathy (DPN).

Study Start Date: Nov. 17

Study Type: INTERVENTIONAL

Condition: Diabetic Peripheral Neuropathic Pain

Intervention: DRUG: Suzetrigine

Tablets for oral administration

DRUG: Placebo (matched to SUZ)

Placebo matched to SUZ for oral administration.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Vertex Pharmaceuticals ...